Han Ting Chang

USPTO Granted Patents = 30 (Patent Applications = 3)

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.2

ph-index = 13

Forward Citations = 433(Granted Patents)

Location History:

Santa Clara, CA (US) (2003)
Livermore, CA (US) (2002 - 2013)

Company Filing History:

12 out of 302

Symyx Technologies, Inc.

where one patent can have more than one assignee

Years Active: 2002-2013

Loading Chart...

30 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8349305 - Crosslinked amine polymers (2013-01-08),

2. 8282960 - Ion binding compositions (2012-10-09),

3. 8216560 - Ion binding polymers and uses thereof (2012-07-10),

4. 8192758 - Ion binding compositions (2012-06-05),

5. 7854924 - Methods and compositions for treatment of ion imbalances (2010-12-21),

6. 7776319 - Methods and compositions for treatment of ion imbalances (2010-08-17),

7. 7767768 - Crosslinked amine polymers (2010-08-03),

8. 7754199 - Pharmaceutical compositions comprising crosslinked amine polymer with repeat units derived from polymerization of tertiary amines (2010-07-13),

9. RE41316 - Crosslinked amine polymers (2010-05-03),

10. 7589238 - Treatment of hyperphosphatemia using crosslinked small molecule amine polymers (2009-09-15),

11. 7556799 - Ion binding polymers and uses thereof (2009-07-07),

12. 7488495 - Ion binding polymers and uses thereof (2009-02-10),

13. 7459502 - Pharmaceutical compositions comprising crosslinked polyamine polymers (2008-12-02),

14. 7449605 - Crosslinked amine polymers (2008-11-11),

15. 7429394 - Ion binding compositions (2008-09-30),

Title: Innovations and Contributions of Han Ting Chang in Ion Imbalance Treatments

Introduction

Han Ting Chang, based in Livermore, California, is a prolific inventor with a remarkable portfolio of 30 patents. His groundbreaking work primarily focuses on innovations that address ion imbalances, with significant implications in the pharmaceutical field.

Latest Patents

Among his latest patents, Han Ting Chang has developed novel formulations such as crosslinked amine polymers. This invention presents methods and compositions aimed at treating ion imbalances, particularly through polymeric and pharmaceutical compositions that benefit therapeutic and prophylactic applications. For instance, these compositions are designed for the treatment of renal diseases and hyperphosphatemia.

Additionally, he has introduced core-shell compositions and related pharmaceutical formulations for treating phosphate imbalance disorders, hypertension, chronic heart failure, end-stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, and sodium overload. These innovations play a crucial role in enhancing patient care and improving health outcomes.

Career Highlights

Han Ting Chang has had an impressive career, contributing significantly to the field of biomedical engineering and pharmaceutical sciences. His work at notable companies such as Symyx Technologies, Inc. and Ilypsa, Inc. has further solidified his reputation as an influential inventor.

Collaborations

Throughout his career, Han has collaborated with esteemed colleagues, including Dominique Charmot and Eric F Connor. These partnerships have facilitated the exchange of ideas and fostered innovation, leading to the successful development of his patented technologies.

Conclusion

In conclusion, Han Ting Chang's contributions to the field of ion imbalance treatments are substantial and impactful. His innovative patents and collaborative spirit continue to advance the understanding and treatment of critical health issues, showcasing the importance of inventors in modern medicine. As he continues to innovate, the pharmaceutical landscape is likely to benefit from his expertise and creativity.

This text is generated by artificial intelligence and may not be accurate.